[1] |
El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review[J]. Gut, 2014, 63(6): 871-880.
|
[2] |
Subramanian CR, Triadafilopoulos G. Refractory gastroesophageal reflux disease[J]. Gastroenterol Rep(Oxf), 2015, 3(1): 41-53.
|
[3] |
El-Serag H, Becher A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies[J]. Aliment Pharmacol Ther2010, 32(6): 720-737.
|
[4] |
Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium[J]. Curr Gastroenterol Rep, 2010, 12(6): 448-457.
|
[5] |
Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis[J]. Clin Gastroenterol Hepatol, 2013, 11(5): 483-490.
|
[6] |
Zirk-Sadowski J, Masoli JA, Delgado J, et al. Proton-pump inhibitors and long-term risk of community-acquired pneumonia in older adults[J]. J Am Geriatr Soc, 2018, 66(7): 1332-1338.
|
[7] |
Hung YP, Lee JC, Tsai BY, et al. Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration[J/OB]. J Microbiol Immunol Infect, 2019, S1684-1182(19)30088-X.
|
[8] |
Fry LC, Mönkemüller K, Malfertheiner P. Systematic review: endoluminal therapy for gastro-oesophageal reflux disease: evidence from clinical trials[J]. Eur J Gastroenterol Hepatol, 2007, 19(12): 1125-1139.
|
[9] |
Tam WC, Schoeman MN, Zhang Q, et al. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease[J]. Gut, 2003, 52(4): 479-485.
|
[10] |
Hummel K, Richards W. Endoscopic treatment of gastroesophageal reflux disease[J]. Surg Clin North Am, 2015, 95(3): 653-667.
|
[11] |
Viswanath Y, Maguire N, Obuobi RB, et al. Endoscopic day case antireflux radiofrequency(Stretta) therapy improves quality of life and reduce proton pump inhibitor(PPI) dependency in patients with gastro-oesophageal reflux disease: a prospective study from a UK tertiary centre[J]. Frontline Gastroenterol, 2019, 10(2): 113-119.
|
[12] |
Liu PP, Meng QQ, Lin H, et al. Radiofrequency ablation is safe and effective in the treatment of Chinese patients with gastroesophageal reflux disease: A single-center prospective study[J]. J Dig Dis, 2019, 20(5): 229-234.
|
[13] |
Liang WT, Wang ZG, Wang F, et al. Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study[J]. BMC Gastroenterol, 2014, 14: 178.
|
[14] |
Noar M, Squires P, Noar E, et al. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later[J]. Surg Endosc, 2014, 28(8): 2323-2333.
|
[15] |
Kalapala R, Shah H, Nabi Z, et al. Treatment of gastroesophageal reflux disease using radiofrequency ablation(Stretta procedure): An interim analysis of a randomized trial[J]. Indian J Gastroenterol, 2017, 36(5): 337-342.
|
[16] |
Coron E, Sebille V, Cadiot G, et al. Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients[J]. Aliment Pharmacol Ther, 2008, 28(9): 1147-1158.
|
[17] |
He S, Xu F, Xiong X, et al. Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up[J]. Medicine(Baltimore), 2020, 99(3): e18610.
|
[18] |
Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis[J]. Surg Laparosc Endosc Percutan Tech, 2012, 22(4): 283-288.
|
[19] |
Fass R, Cahn F, Scotti DJ, et al. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease[J]. Surg Endosc, 2017, 31(12): 4865-4882.
|
[20] |
Lipka S, Kumar A, Richter JE. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2015, 13(6): 1058-1067. e1.
|
[21] |
Triadafilopoulos G. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease[J]. World J Gastroenterol, 2014, 20(24): 7730-7738.
|
[22] |
Li X, Zhang XB, Hu HQ, et al. Effect and safety of peroral endoscopic cardial constriction for gastroesophageal reflux disease[J]. Chin Med J(Engl), 2017, 130(14): 1749-1750.
|
[23] |
Hu HQ, Li HK, Xiong Y, et al. Peroral endoscopic cardial constriction in gastroesophageal reflux disease[J]. Medicine (Baltimore), 2018, 97(15): e0169.
|
[24] |
Satodate H, Inoue H, Yoshida T, et al. Circumferential EMR of carcinoma arising in Barrett's esophagus: case report[J]. Gastrointest Endosc, 2003, 58(2): 288-292.
|
[25] |
Patil G, Dalal A, Maydeo A. Feasibility and outcomes of anti-reflux mucosectomy for proton pump inhibitor dependent gastroesophageal reflux disease: First Indian study(with video)[J]. Dig Endosc, 2020, 32(5): 745-752.
|
[26] |
Inoue H, Ito H, Ikeda H, et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study[J]. Annals of gastroenterology, 2014, 27(4): 346-351.
|
[27] |
Sumi K, Inoue H, Kobayashi Y, et al. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases[J]. Dig Endosc, 2020, DOI: 10.1111/den.13727.
|
[28] |
Trad KS, Barnes WE, Prevou ER, et al. The TEMPO Trial at 5 Years: Transoral Fundoplication(TIF 2.0) Is Safe, Durable, and Cost-effective[J]. Surg Innov, 2018, 25(2): 149-157.
|
[29] |
Testoni PA, Testoni S, Distefano G, et al. Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years[J]. Endosc Int Open, 2019, 7(5): E647-E654.
|
[30] |
Zacherl J, Roy-Shapira A, Bonavina L, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial[J]. Surg Endosc, 2015, 29(1): 220-229.
|
[31] |
Kim HJ, Kwon CI, Kessler WR, et al. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE endoscopic stapling device[J]. Surg Endosc, 2016, 30(8): 3402-3408.
|
[32] |
Richards WO, Houston HL, Torquati A, et al. Paradigm shift in the management of gastroesophageal reflux disease[J]. Ann Surg, 2003, 237(5): 638-647.
|
[33] |
Liang WT, Wu JM, Hu ZW, et al. Laparoscopic Nissen fundoplication is more effective in treating patients with GERD-related chronic cough than Stretta radiofrequency[J]. Minerva Chir, 2014, 69(3): 121-127.
|
[34] |
Hu ZW, Wang ZG, Zhang Y, et al. A preliminary investigation of anti-reflux intervention for gastroesophageal reflux related childhood-to-adult persistent asthma[J]. Ann Surg Innov Res, 2014, 8: 3.
|
[35] |
Liang WT, Wu JN, Wang F, et al. Five-year follow-up of a prospective study comparing laparoscopic Nissen fundoplication with Stretta radiofrequency for gastroesophageal reflux disease[J]. Minerva Chir, 2014, 69(4): 217-223.
|
[36] |
Liang WT, Yan C, Wang ZG, et al. Early and Midterm outcome after laparoscopic fundoplication and a minimally invasive endoscopic procedure in patients with gastroesophageal reflux disease: a prospective observational Study[J]. J Laparoendosc Adv Surg Tech A, 2015, 25(8): 657-661.
|
[37] |
Hu Z, Wu J, Wang Z, et al. Outcome of Stretta radiofrequency and fundoplication for GERD-related severe asthmatic symptoms[J]. Front Med, 2015, 9(4): 437-443.
|
[38] |
Yan C, Liang WT, Wang ZG, et al. Comparison of Stretta procedure and toupet fundoplication for gastroesophageal reflux disease-related extra-esophageal symptoms[J]. World J Gastroenterol, 2015, 21(45): 12882-12887.
|
[39] |
Zhang C, Wu J, Hu Z, et al. Diagnosis and anti-reflux therapy for gerd with respiratory symptoms: a study using multichannel intraluminal impedance-pH monitoring[J]. PLoS One, 2016, 11(8): e0160139.
|